Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)
The PROMISE study is the first study to test healthy people who may be at risk for early warnings signs of a blood cancer called multiple myeloma.
Multiple myeloma is a type of blood cancer that occurs in the bone marrow. Before a person develops multiple myeloma, their marrow begins to make abnormal cells and proteins, which can be an early warning sign of the disease.
We're inviting qualifying adults with higher risks for multiple myeloma to participate in a screening study for early warning signs of the disease.
We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer.
Your participation may help researchers find new ways to prevent and treat blood cancer.
How To Join and Get Screened for Free:
1. Take a short survey and decide whether to go to the next step.
2. Once you have completed the enrollment and are qualified for a free screening, we will send a collection kit to you at no cost.
3. When the kit arrives, it will contain instructions for how to schedule your free screening at a Quest Diagnostics lab near you where they will collect a small amount of blood.
4. We will check your blood sample for certain proteins that we call “precursor conditions for multiple myeloma.
5. We will notify all participants of their results.
You may be eligible for this study if you meet the following criteria:
- Conditions: healthy,cancer,multiple mylemoa,myeloma,MGUS,cancer screening,smoldering multiple myeloma,monoclonal gammopathy of undetermined significance,waldentrom macroglobulinemia
Age: Between 40 Years - 75 Years
Gender: Male or Female
Two groups of adults, age 40-75, qualify for a free screening:
1.) African Americans
AND / OR
2.) People of Any Race Who Have a Parent, Sibling, or Child with:
Multiple myeloma OR one of these related conditions:
· Monoclonal Gammopathy of Undetermined Significance (MGUS)
· Smoldering Multiple Myeloma
· Waldenström Macroglobulinemia